510(k) Report

510(k) · Cleared

Cleared

Prodigy Blood Glucose Test System

K060467510(k) TraditionalCleared Jul 13, 2006140-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Devices, Inc. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Jul 13, 2006 as substantially equivalent to K042005 (Taidoc Technology Corporation, 2004) after a 140-day review. Its family tree reaches back 1 generation to 2004. 17 later devices descend from it.

Decided
Jul 13, 2006
Review
140 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K042005 (2004). 17 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2016: 2 descendants cleared2008: 1 descendant cleared2013: 4 descendants cleared2009: 1 descendant cleared2010: 4 descendants cleared2017: 1 descendant cleared2014: 2 descendants cleared2015: 2 descendants clearedK042005 · Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222 · Taidoc Technology Corporation · 2004200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 5 descendants3 generations forward: 7 descendants4 generations forward: 3 descendants K042005 · Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222 · Taidoc Technology Corporation · 20040
  1. Root · 1 generation backK042005 Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222Taidoc Technology Corporation · 2004
  2. This deviceK060467 Prodigy Blood Glucose Test SystemDiagnostic Devices, Inc. · 2006
  3. Descendant · cites it directly · 14 of its ownK073118 Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc. · 2008
  4. Descendant · 2 generations on · 6 of its ownK091815 Supercheck 1 Blood Glucose Monitoring System, Model 6268Biotest Medical Corp. · 2009
  5. Descendant · 2 generations on · 3 of its ownK122338 Preferred Blood Glucose Monitoring SystemProdigy Diabetes Care, LLC · 2013
  6. Descendant · cites it directly · 1 of its ownK160038 UniStrip1 Generic Blood Glucose Test StripsOk Biotech Co., Ltd. · 2016
  7. Descendant · 3 generations on · 1 of its ownK141914 Prodigy Autocode Eject Blood Glucose Monitoring SystemOk Biotech Co., Ltd. · 2015

Showing 5 of 17 descendants. See all descendants

Descendants cleared per year

2008: 12009: 12010: 42013: 42014: 22015: 22016: 22017: 1
2008high 4 (2010) · low 0 (2011)2026

Most influential descendants

Showing 5 of 17 · See all
  • K073118Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc. · 2008 · cites it directly14descendants
  • K091815Supercheck 1 Blood Glucose Monitoring System, Model 6268Biotest Medical Corp. · 2009 · 2 generations on6descendants
  • K122338Preferred Blood Glucose Monitoring SystemProdigy Diabetes Care, LLC · 2013 · 2 generations on3descendants
  • K160038UniStrip1 Generic Blood Glucose Test StripsOk Biotech Co., Ltd. · 2016 · cites it directly1descendant
  • K141914Prodigy Autocode Eject Blood Glucose Monitoring SystemOk Biotech Co., Ltd. · 2015 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K042005Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222Taidoc Technology Corporation2004—
0 (this device)K060467Prodigy Blood Glucose Test SystemDiagnostic Devices, Inc.2006—
+1K073118Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc.2008—
+2K091815Supercheck 1 Blood Glucose Monitoring System, Model 6268Biotest Medical Corp.2009—
+2K122338Preferred Blood Glucose Monitoring SystemProdigy Diabetes Care, LLC2013—
+1K160038UniStrip1 Generic Blood Glucose Test StripsOk Biotech Co., Ltd.2016—
+3K141914Prodigy Autocode Eject Blood Glucose Monitoring SystemOk Biotech Co., Ltd.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
200910
201040
201340
201420
201520
201620
201710
FIG. 1 — Lineage of K060467, 2004–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042005Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222
Summary page 1
…system and Quality Control Material Safety and Effective Information Predicate Device: Claim of Substantial Equivalence (SE) is made to TaiDoc Technology Corporation. K042005, Achtung TD-4207/ Clever Chek TD-4209/ Clever Chek TD-4222 Glucose Test Systems. Indications for Use: The Prodigy Blood Glucos…
Taidoc Technology Corporation2004—

Also cleared against K042005: 2 other devices →

What descends from it? (17)

See all 17

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K073118Prodigy Voice Blood Glucose Monitoring SystemDiagnostic Devices, Inc.200814
K160038UniStrip1 Generic Blood Glucose Test StripsOk Biotech Co., Ltd.20161

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K073118 (Diagnostic Devices, Inc., 2008) has gone furthest, with 14 descendants of its own.
  • 2 other devices also cite its predicate K042005.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The Prodigy Blood Glucose Test System is intended to be used for the quantitative

measurement of glucose in capillary whole blood from the fingertip and palm. It is

intended for use by healthcare professionals and people with diabetes mellitus at home

as an aid in monitoring the effectiveness of diabetes control program. It is not intended

for the diagnosis of or screening for diabetes mellitus, and not intended for use on

neonates.

The Prodigy meter is to be used with the Prodigy Blood Glucose Test Strip, and the

Prodigy Glucose Control Solutions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060467: Prodigy Blood Glucose Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K060467

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026